Meridian Wealth Management’s Amgen AMGN Stock Holding History

Meridian Wealth Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$436K	Buy	+1,700	New	+$582K	0.01%	584

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Meridian Wealth Management's AMGN Position: Q2 2026 in Review

Meridian Wealth Management reduced its Amgen (AMGN) stake by 1.3% in Q2 2026, selling an estimated $63K and leaving 14,339 shares worth $5.19M. The position accounts for 0.16% of the portfolio, ranked #125.

Meridian Wealth Management first reported a position in AMGN in Q1 2018 and has held it in 31 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Meridian Wealth Management held 14,339 shares of Amgen worth $5.19M as of Q2 2026.
Meridian Wealth Management sold 184 Amgen shares in Q2 2026, an estimated $63K.
Amgen made up 0.16% of Meridian Wealth Management's portfolio in Q2 2026, its #125 holding.
Meridian Wealth Management first reported a position in Amgen in Q1 2018 and has held it in 31 quarters since.
3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Meridian Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.